Assignee
NEUFORM PHARMACEUTICALS INC
US·2 granted patents·1 pending application·0 citations·filing 2016–2017
Top patents by PatentIndex Score
3 records- 0132US9968606B2Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereofNEUFORM PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·0 cites·29 claims
- 0230US9688659B2Deuterated compounds for treating hematologic malignancies, and compositions and methods thereofNEUFORM PHARMACEUTICALS INC·Filed 2016·Granted Jun 27, 2017·0 cites·14 claims
- 0330US2020330444A1Deuterated compounds for treating pain and related diseases and conditions, and compositions and methods thereofNEUFORM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →